Perseus

What Perseus does

Perseus BV operates under the brand 3BIO and is a Belgian-headquartered regulatory consultancy specializing in the intersection of biodiversity, biosafety, and biotechnology regulation within the EU framework. The firm is organized around three integrated pillars: Biodiversity (covering Access and Benefit Sharing laws, the Nagoya Protocol, Digital Sequence Information, and the International Treaty on Plant Genetic Resources for Food and Agriculture), Biosafety (covering biorisk management, permits, infrastructure, audits, and biosafety officer services), and Biotech Regulatory (covering GMO development, market authorization, NGTs, and post-market stewardship). Services span compliance analysis, audits, training, permits, regulatory strategy, and studies. The team consists of 18 multidisciplinary professionals with 20+ years of combined expertise, and the firm cites participation in five or more EU-funded research projects as evidence of regulatory standing.

3BIO monetizes primarily through project-based professional services, with pricing structured around bespoke quotes rather than published tiers. The GTM motion is sales-led: direct expert consultation drives engagement, supplemented by industry-specific content marketing and an educational platform (ABS E-Learning). Revenue is concentrated in enterprise and institutional biotech buyers, with no disclosed SMB or self-serve channel. Three proprietary platforms supplement the consulting practice: ABS Navigator (a curated, regularly updated knowledge base of national ABS laws with a Wizard that analyzes obligations by source country and utilization type), ABS E-Learning (an online training platform for ABS and Nagoya Protocol compliance), and OrBios (a cloud-based biorisk management platform for tracking deadlines, authorizations, and equipment revalidation, listed as coming soon). The firm operates from Ghent, Belgium, and primarily serves EU-based biotech organizations and international companies operating within the EU regulatory perimeter across eight vertical segments: pharmaceuticals, animal breeding, plant breeding, green biotech, industrial biotech, cosmetics, fragrances, and food.

Name

Perseus

Legal name

Perseus BV

Website

https://perseus.eu

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

3BIO (Perseus BV) is a Belgian regulatory consultancy serving EU biotech organizations with integrated biodiversity, biosafety, and biotech regulatory advisory. The firm combines expert consulting with proprietary compliance platforms (ABS Navigator, ABS E-Learning, OrBios) across eight industry verticals.

Ownership category

akta.pro rank

Product category

Biotech Regulatory Consultancy

NAICS

Other Scientific and Technical Consulting Services (54169), Professional, Scientific, and Technical Services (541)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAKAA

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYBPADANAJ

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation

Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation

SECONDARYAFALAAAB

Food Safety Auditing & Inspection Services (GFSI/Third-Party Audits)

Agriculture & Food Production/Food Safety, Testing & Certification/Food Testing Laboratories (Microbiological, Chemical, Allergen)

Keywords

• Biotech regulatory consultancy
• Biodiversity compliance services
• Biosafety advisory services
• ABS compliance management
• Nagoya Protocol compliance

Headquarters

HQ city

Sint-martens-latem

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Regulatory Consultancy Services: Professional advisory services covering biodiversity compliance, biosafety management, and biotech regulatory strategy. Services include compliance analysis, audits, permits, trainings, and regulatory strategy development for biotech organizations navigating EU regulatory frameworks.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

3BIO provides integrated regulatory consultancy services across three pillars — Biodiversity (Nagoya Protocol, ABS, DSI, ITPGRFA, BBNJ), Biosafety (biorisk management, permits, audits, training), and Biotech Regulatory (GMO development, market authorization, NGTs, stewardship) — for biotech organizations operating primarily in the EU. The consultancy is augmented by three proprietary digital platforms: ABS Navigator, ABS E-Learning, and OrBios.

Product overview

3BIO is a regulatory consultancy offering a suite of proprietary platforms alongside consulting services. The three integrated regulatory pillars—Biodiversity, Biosafety, and Biotech Regulatory—are supported by proprietary tools: ABS Navigator (for ABS law analysis), ABS E-Learning (for training), and OrBios (for biorisk management). The company serves multiple industries including pharmaceuticals, animal breeding, plant breeding, green biotech, industrial biotech, cosmetics, fragrances, and food sectors.

Differentiator

Problem solved

Functional benefit

Brands

• ABS Navigator: Extensive knowledge base of curated, up-to-date national ABS laws with a Wizard enabling rapid analysis of obligations based on source country and utilization type
• ABS E-Learning
• OrBios

Products and services

• ABS Navigator Proprietary platform providing a curated, up-to-date knowledge base of national Access and Benefit Sharing (ABS) laws, with a Wizard that enables rapid analysis of obligations based on source country and utilization type. Aimed at biotech organizations that need to determine ABS compliance requirements for genetic resources and Digital Sequence Information (DSI).
• ABS E-Learning Online learning platform providing essential knowledge on ABS and the Nagoya Protocol, tailored to the organization's specific needs without straining budgets or disrupting workflows. Designed for biotech organizations that need scalable training for internal teams on biodiversity compliance.
• OrBios Cloud-based platform designed to streamline and oversee all facets of biorisk management, tracking deadlines, authorizations, and equipment revalidation. Aimed at biotech organizations that need systematic oversight of biosafety obligations across laboratory and operational settings.
• Biodiversity Regulatory Consultancy Advisory and compliance services covering Access and Benefit Sharing (ABS) laws, the Nagoya Protocol, DSI, ITPGRFA, and BBNJ. Includes compliance analysis, audits, permits, training, and regulatory strategy for biotech organizations working with genetic resources and DSI.
• Biosafety Regulatory Consultancy Advisory services covering biorisk management, biosafety infrastructure and construction, risk assessment, audits, training, permits, and compliance analysis. Aimed at biotech organizations needing oversight of biological-material risk in laboratory and operational environments.
• Biotech Regulatory Consultancy Advisory services covering regulatory analysis, policy and strategy, regulatory studies, GMO development trials, market authorization, post-market compliance, and stewardship (including NGTs). Designed to take biotech innovations from development through to market entry and post-market obligations.

Quantifiable outcome

• 20+ years of combined expertise across the team
• +2 more outcomes

Segments8 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• CTI Clinical Trial & Consulting Services: Biotech and pharma regulatory and clinical consulting firm supporting product development, market authorization, and compliance — overlapping with 3BIO's biotech regulatory and biosafety pillars.
• Pharmalex: Regulatory affairs and compliance consultancy for the pharma and biotech industry. Comparable to 3BIO in offering expert regulatory advisory across product development lifecycles and quality compliance.
• ProPharma Group: Regulatory compliance, quality, and pharmacovigilance consulting for pharma and biotech. Comparable to 3BIO's biosafety/quality compliance and biotech regulatory offerings.
• Voisin Consulting Life Sciences: Life sciences regulatory and strategic consulting firm supporting biotech, pharma, and medtech clients across product development. Direct overlap with 3BIO's integrated regulatory strategy services for biotech.
• ERA Consulting Group: Specialized regulatory affairs consultancy serving biotech and pharma clients on global submissions and GxP compliance. Closely comparable to 3BIO's biotech regulatory pillar in service type and customer base.

Others

• ABSint: Belgian-based technology and consulting entity listed in the same corporate footer as Perseus BV. Likely an affiliated or related-party organization with overlapping EU-based regulatory or biosafety expertise.
• Biotechnology Innovation Organization (BIO): Industry trade association representing the biotech sector with significant regulatory policy influence. Thematically comparable as a stakeholder shaping the EU/US regulatory environment that 3BIO helps clients navigate.

Broad incumbents

• Eurofins Scientific: Global bioanalytical testing and consulting group serving pharma, food, cosmetics, and industrial biotech — overlapping with 3BIO's multi-vertical regulatory and biosafety positioning, but at enterprise scale.
• Charles River Laboratories: Large CRO offering biosafety testing, regulatory support, and life sciences services. Overlaps with 3BIO's biosafety pillar and broader biotech regulatory support, though at much larger scale.
• NSF (formerly NSF International): Global public health and safety organization offering biosafety, regulatory, and certification services across multiple industries including biotech. Comparable as a broader incumbent with overlapping biosafety and regulatory advisory capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/perseus-bvba

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Perseus